TY - JOUR AU - Fleisch, H. AU - Russell, R. G. AU - Francis, M. D. PY - 1969 DA - 1969// TI - Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo JO - Science. VL - 165 UR - https://doi.org/10.1126/science.165.3899.1262 DO - 10.1126/science.165.3899.1262 ID - Fleisch1969 ER - TY - JOUR AU - Fleisch, H. AU - Russell, R. G. AU - Straumann, F. PY - 1966 DA - 1966// TI - Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis JO - Nature. VL - 212 UR - https://doi.org/10.1038/212901a0 DO - 10.1038/212901a0 ID - Fleisch1966 ER - TY - JOUR AU - Francis, M. D. AU - Russell, R. G. AU - Fleisch, H. PY - 1969 DA - 1969// TI - Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo JO - Science. VL - 165 UR - https://doi.org/10.1126/science.165.3899.1264 DO - 10.1126/science.165.3899.1264 ID - Francis1969 ER - TY - JOUR AU - Russell, R. G. AU - Fleisch, H. PY - 1970 DA - 1970// TI - Inorganic pyrophosphate and pyrophosphatases in clcification and calcium homeostasis JO - Clin Orthop Relat Res VL - 69 UR - https://doi.org/10.1097/00003086-197003000-00008 DO - 10.1097/00003086-197003000-00008 ID - Russell1970 ER - TY - JOUR AU - Russell, R. G. PY - 2011 DA - 2011// TI - Bisphosphonates: the first 40 years JO - Bone. VL - 49 UR - https://doi.org/10.1016/j.bone.2011.04.022 DO - 10.1016/j.bone.2011.04.022 ID - Russell2011 ER - TY - JOUR AU - Ebetino, F. H. AU - Hogan, A. M. AU - Sun, S. AU - Tsoumpra, M. K. AU - Duan, X. AU - Triffitt, J. T. PY - 2011 DA - 2011// TI - The relationship between the chemistry and biological activity of the bisphosphonates JO - Bone. VL - 49 UR - https://doi.org/10.1016/j.bone.2011.03.774 DO - 10.1016/j.bone.2011.03.774 ID - Ebetino2011 ER - TY - JOUR AU - Rogers, M. J. AU - Ji, X. AU - Russell, R. G. AU - Blackburn, G. M. AU - Williamson, M. P. AU - Bayless, A. V. PY - 1994 DA - 1994// TI - Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum JO - Biochem J VL - 303 UR - https://doi.org/10.1042/bj3030303 DO - 10.1042/bj3030303 ID - Rogers1994 ER - TY - JOUR AU - Luckman, S. P. AU - Hughes, D. E. AU - Coxon, F. P. AU - Graham, R. AU - Russell, G. AU - Rogers, M. J. PY - 1998 DA - 1998// TI - Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras JO - J Bone Miner Res VL - 13 UR - https://doi.org/10.1359/jbmr.1998.13.4.581 DO - 10.1359/jbmr.1998.13.4.581 ID - Luckman1998 ER - TY - JOUR AU - Baron, R. AU - Ferrari, S. AU - Russell, R. G. PY - 2011 DA - 2011// TI - Denosumab and bisphosphonates: different mechanisms of action and effects JO - Bone. VL - 48 UR - https://doi.org/10.1016/j.bone.2010.11.020 DO - 10.1016/j.bone.2010.11.020 ID - Baron2011 ER - TY - JOUR AU - Bone, H. G. AU - Hosking, D. AU - Devogelaer, J. P. AU - Tucci, J. R. AU - Emkey, R. D. AU - Tonino, R. P. PY - 2004 DA - 2004// TI - Ten years' experience with alendronate for osteoporosis in postmenopausal women JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa030897 DO - 10.1056/NEJMoa030897 ID - Bone2004 ER - TY - JOUR AU - Tonino, R. P. AU - Meunier, P. J. AU - Emkey, R. AU - Rodriguez-Portales, J. A. AU - Menkes, C. J. AU - Wasnich, R. D. PY - 2000 DA - 2000// TI - Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III osteoporosis treatment study group JO - J Clin Endocrinol Metab VL - 85 ID - Tonino2000 ER - TY - JOUR AU - Adami, S. AU - Baroni, M. C. AU - Broggini, M. AU - Carratelli, L. AU - Caruso, I. AU - Gnessi, L. PY - 1993 DA - 1993// TI - Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin JO - Osteoporos Int VL - 3 UR - https://doi.org/10.1007/BF01623004 DO - 10.1007/BF01623004 ID - Adami1993 ER - TY - JOUR AU - Brown, J. E. AU - Cook, R. J. AU - Lipton, A. AU - Costa, L. AU - Coleman, R. E. PY - 2010 DA - 2010// TI - Prognostic factors for skeletal complications from metastatic bone disease in breast cancer JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-010-0981-1 DO - 10.1007/s10549-010-0981-1 ID - Brown2010 ER - TY - JOUR AU - Makhoul, I. AU - Montgomery, C. O. AU - Gaddy, D. AU - Suva, L. J. PY - 2016 DA - 2016// TI - The best of both worlds - managing the cancer, saving the bone JO - Nat Rev Endocrinol VL - 12 UR - https://doi.org/10.1038/nrendo.2015.185 DO - 10.1038/nrendo.2015.185 ID - Makhoul2016 ER - TY - JOUR AU - Denoix, J. M. AU - Thibaud, D. AU - Riccio, B. PY - 2003 DA - 2003// TI - Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial JO - Equine Vet J VL - 35 UR - https://doi.org/10.2746/042516403776014226 DO - 10.2746/042516403776014226 ID - Denoix2003 ER - TY - JOUR AU - Whitfield, C. T. AU - Schoonover, M. J. AU - Holbrook, T. C. AU - Payton, M. E. AU - Sippel, K. M. PY - 2016 DA - 2016// TI - Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses JO - Am J Vet Res VL - 77 UR - https://doi.org/10.2460/ajvr.77.2.167 DO - 10.2460/ajvr.77.2.167 ID - Whitfield2016 ER - TY - JOUR AU - Fan, T. M. AU - Lorimier, L. P. AU - Garrett, L. D. AU - Lacoste, H. I. PY - 2008 DA - 2008// TI - The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis JO - J Vet Intern Med VL - 22 UR - https://doi.org/10.1111/j.1939-1676.2008.0046.x DO - 10.1111/j.1939-1676.2008.0046.x ID - Fan2008 ER - TY - JOUR AU - Waguespack, R. AU - Hanson, R. R. PY - 2010 DA - 2010// TI - Navicular syndrome in equine patients anatomy, causes, and diagnosis JO - Compend Contin Educ Vet VL - 32 ID - Waguespack2010 ER - TY - JOUR AU - Nieto, J. E. AU - Maher, O. AU - Stanley, S. D. AU - Knych, H. K. AU - Snyder, J. R. PY - 2013 DA - 2013// TI - Pharmacokinetics, pharmacodynamics, and safety of zoledronic acid in horses JO - Am J Vet Res VL - 74 UR - https://doi.org/10.2460/ajvr.74.4.550 DO - 10.2460/ajvr.74.4.550 ID - Nieto2013 ER - TY - JOUR AU - Coudry, V. AU - Thibaud, D. AU - Riccio, B. AU - Audigie, F. AU - Didierlaurent, D. AU - Denoix, J. M. PY - 2007 DA - 2007// TI - Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column JO - Am J Vet Res VL - 68 UR - https://doi.org/10.2460/ajvr.68.3.329 DO - 10.2460/ajvr.68.3.329 ID - Coudry2007 ER - TY - JOUR AU - Gough, M. R. AU - Thibaud, D. AU - Smith, R. K. PY - 2010 DA - 2010// TI - Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial JO - Equine Vet J VL - 42 UR - https://doi.org/10.1111/j.2042-3306.2010.00120.x DO - 10.1111/j.2042-3306.2010.00120.x ID - Gough2010 ER - TY - STD TI - Mitchell A, Wright G, Sampson SN, Martin M, Cummings K, Gaddy D, et al. Clodronate improves lameness in horses without changing bone turnover markers. Equine Vet J. 2018. ID - ref22 ER - TY - JOUR AU - Kamm, L. AU - McIlwraith, W. AU - Kawcak, C. PY - 2008 DA - 2008// TI - A review of the efficacy of tiludronate in the horse JO - J Equine Vet Sci VL - 28 UR - https://doi.org/10.1016/j.jevs.2008.02.007 DO - 10.1016/j.jevs.2008.02.007 ID - Kamm2008 ER - TY - JOUR AU - Liepe, K. AU - Kropp, J. AU - Hliscs, R. AU - Franke, W. G. PY - 2000 DA - 2000// TI - Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy JO - Clin Nucl Med VL - 25 UR - https://doi.org/10.1097/00003072-200011000-00009 DO - 10.1097/00003072-200011000-00009 ID - Liepe2000 ER - TY - STD TI - Kato Y, Hiasa M, Ichikawa R, Hasuzawa N, Kadowaki A, Iwatsuki K, et al. Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc Natl Acad Sci U S A. 2017. ID - ref25 ER - TY - JOUR AU - Lopez-Posadas, R. AU - Mascaraque, C. AU - Gonzalez, R. AU - Suarez, M. D. AU - Zarzuelo, A. AU - Martinez-Augustin, O. PY - 2016 DA - 2016// TI - The bisphosphonate Pamidronate is an intestinal Antiinflammatory agent in rat and mouse experimental colitis JO - Inflamm Bowel Dis VL - 22 UR - https://doi.org/10.1097/MIB.0000000000000920 DO - 10.1097/MIB.0000000000000920 ID - Lopez-Posadas2016 ER - TY - JOUR AU - Richbourg, H. A. AU - Mitchell, C. F. AU - Gillett, A. N. AU - McNulty, M. A. PY - 2018 DA - 2018// TI - Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial JO - BMC Vet Res VL - 14 UR - https://doi.org/10.1186/s12917-018-1423-2 DO - 10.1186/s12917-018-1423-2 ID - Richbourg2018 ER - TY - JOUR AU - Delguste, C. AU - Amory, H. AU - Doucet, M. AU - Piccot-Crezollet, C. AU - Thibaud, D. AU - Garnero, P. PY - 2007 DA - 2007// TI - Pharmacological effects of tiludronate in horses after long-term immobilization JO - Bone. VL - 41 UR - https://doi.org/10.1016/j.bone.2007.05.005 DO - 10.1016/j.bone.2007.05.005 ID - Delguste2007 ER - TY - STD TI - Adler R. Management of endocrine disease: atypical femoral fractures: risks and benefits of long term treatment of osteoporosis with anti-resorptive therapy. Eur J Endocrinol. 2018. ID - ref29 ER - TY - JOUR AU - Gnant, M. AU - Mlineritsch, B. AU - Schippinger, W. AU - Luschin-Ebengreuth, G. AU - Postlberger, S. AU - Menzel, C. PY - 2009 DA - 2009// TI - Endocrine therapy plus zoledronic acid in premenopausal breast cancer JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0806285 DO - 10.1056/NEJMoa0806285 ID - Gnant2009 ER - TY - JOUR AU - Coleman, R. AU - Cameron, D. AU - Dodwell, D. AU - Bell, R. AU - Wilson, C. AU - Rathbone, E. PY - 2014 DA - 2014// TI - Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70302-X DO - 10.1016/S1470-2045(14)70302-X ID - Coleman2014 ER - TY - JOUR AU - Wilson, C. AU - Bell, R. AU - Hinsley, S. AU - Marshall, H. AU - Brown, J. AU - Cameron, D. PY - 2018 DA - 2018// TI - Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study JO - Eur J Cancer VL - 94 UR - https://doi.org/10.1016/j.ejca.2018.02.004 DO - 10.1016/j.ejca.2018.02.004 ID - Wilson2018 ER - TY - JOUR AU - Abrahamsen, B. PY - 2010 DA - 2010// TI - Bisphosphonate adverse effects, lessons from large databases JO - Curr Opin Rheumatol VL - 22 UR - https://doi.org/10.1097/BOR.0b013e32833ad677 DO - 10.1097/BOR.0b013e32833ad677 ID - Abrahamsen2010 ER - TY - JOUR AU - Adler, R. A. PY - 2016 DA - 2016// TI - Bisphosphonates and atypical femoral fractures JO - Curr Opin Endocrinol Diabetes Obes VL - 23 UR - https://doi.org/10.1097/MED.0000000000000287 DO - 10.1097/MED.0000000000000287 ID - Adler2016 ER - TY - JOUR AU - Khosla, S. AU - Burr, D. AU - Cauley, J. AU - Dempster, D. W. AU - Ebeling, P. R. AU - Felsenberg, D. PY - 2007 DA - 2007// TI - Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research JO - J Bone Miner Res VL - 22 UR - https://doi.org/10.1359/jbmr.0707onj DO - 10.1359/jbmr.0707onj ID - Khosla2007 ER - TY - JOUR AU - Recker, R. R. AU - Lewiecki, E. M. AU - Miller, P. D. AU - Reiffel, J. PY - 2009 DA - 2009// TI - Safety of bisphosphonates in the treatment of osteoporosis JO - Am J Med VL - 122 UR - https://doi.org/10.1016/j.amjmed.2008.12.004 DO - 10.1016/j.amjmed.2008.12.004 ID - Recker2009 ER - TY - JOUR AU - Shane, E. AU - Burr, D. AU - Ebeling, P. R. AU - Abrahamsen, B. AU - Adler, R. A. AU - Brown, T. D. PY - 2010 DA - 2010// TI - Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research JO - J Bone Miner Res VL - 25 UR - https://doi.org/10.1002/jbmr.253 DO - 10.1002/jbmr.253 ID - Shane2010 ER - TY - JOUR AU - Pazianas, M. AU - Cooper, C. AU - Ebetino, F. H. AU - Russell, R. G. PY - 2010 DA - 2010// TI - Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis JO - Ther Clin Risk Manag VL - 6 ID - Pazianas2010 ER - TY - JOUR AU - Khosla, S. AU - Bilezikian, J. P. AU - Dempster, D. W. AU - Lewiecki, E. M. AU - Miller, P. D. AU - Neer, R. M. PY - 2012 DA - 2012// TI - Benefits and risks of bisphosphonate therapy for osteoporosis JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2012-1027 DO - 10.1210/jc.2012-1027 ID - Khosla2012 ER - TY - JOUR AU - Lieshout, M. AU - Putzeys, G. AU - Goemaere, S. AU - Straeten, C. AU - Audenaert, E. PY - 2017 DA - 2017// TI - Atypical femoral fractures : three cases and a review of literature JO - Acta Orthop Belg VL - 83 ID - Lieshout2017 ER - TY - JOUR AU - Shane, E. AU - Burr, D. AU - Abrahamsen, B. AU - Adler, R. A. AU - Brown, T. D. AU - Cheung, A. M. PY - 2014 DA - 2014// TI - Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research JO - J Bone Miner Res VL - 29 UR - https://doi.org/10.1002/jbmr.1998 DO - 10.1002/jbmr.1998 ID - Shane2014 ER - TY - JOUR AU - Suva, L. J. AU - Gaddy, D. AU - Perrien, D. S. AU - Thomas, R. L. AU - Findlay, D. M. PY - 2005 DA - 2005// TI - Regulation of bone mass by mechanical loading: microarchitecture and genetics JO - Current osteoporosis reports VL - 3 UR - https://doi.org/10.1007/s11914-005-0003-0 DO - 10.1007/s11914-005-0003-0 ID - Suva2005 ER - TY - JOUR AU - Buza, J. A. AU - Einhorn, T. PY - 2016 DA - 2016// TI - Bone healing in 2016 JO - Clin Cases Miner Bone Metab VL - 13 ID - Buza2016 ER - TY - JOUR AU - Kakar, S. AU - Little, D. AU - Einhorn, T. A. PY - 2009 DA - 2009// TI - Can we improve fixation and outcomes in the treatment of femoral neck fractures? The use of pharmaceuticals JO - J Orthop Trauma VL - 23 UR - https://doi.org/10.1097/BOT.0b013e3181ac64a0 DO - 10.1097/BOT.0b013e3181ac64a0 ID - Kakar2009 ER - TY - JOUR AU - Gerstenfeld, L. C. AU - Sacks, D. J. AU - Pelis, M. AU - Mason, Z. D. AU - Graves, D. T. AU - Barrero, M. PY - 2009 DA - 2009// TI - Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing JO - J Bone Miner Res VL - 24 UR - https://doi.org/10.1359/jbmr.081113 DO - 10.1359/jbmr.081113 ID - Gerstenfeld2009 ER - TY - JOUR AU - Peter, C. P. AU - Cook, W. O. AU - Nunamaker, D. M. AU - Provost, M. T. AU - Seedor, J. G. AU - Rodan, G. A. PY - 1996 DA - 1996// TI - Effect of alendronate on fracture healing and bone remodeling in dogs JO - J Orthop Res VL - 14 UR - https://doi.org/10.1002/jor.1100140113 DO - 10.1002/jor.1100140113 ID - Peter1996 ER - TY - JOUR AU - Goodship, A. E. AU - Walker, P. C. AU - McNally, D. AU - Chambers, T. AU - Green, J. R. PY - 1994 DA - 1994// TI - Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone JO - Ann Oncol VL - 5 ID - Goodship1994 ER - TY - JOUR AU - Lyles, K. W. AU - Colon-Emeric, C. S. AU - Magaziner, J. S. AU - Adachi, J. D. AU - Pieper, C. F. AU - Mautalen, C. PY - 2007 DA - 2007// TI - Zoledronic acid and clinical fractures and mortality after hip fracture JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa074941 DO - 10.1056/NEJMoa074941 ID - Lyles2007 ER - TY - STD TI - Duckworth AD, McQueen MM, Tuck CE, Tobias JH, Wilkinson JM, Biant LC, et al. Effect of Alendronic acid on fracture healing: a multicenter randomized placebo-controlled trial. J Bone Miner Res. 2019. ID - ref49 ER - TY - JOUR AU - Saviola, G. AU - Abdi-Ali, L. AU - Povino, M. R. AU - Campostrini, L. AU - Sacco, S. AU - Carbonare, L. D. PY - 2017 DA - 2017// TI - Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-the ER.O.D.E. study (ERosive osteoarthritis and disodium-clodronate evaluation) JO - Clin Rheumatol VL - 36 UR - https://doi.org/10.1007/s10067-017-3681-y DO - 10.1007/s10067-017-3681-y ID - Saviola2017 ER - TY - JOUR AU - Russell, R. G. AU - Watts, N. B. AU - Ebetino, F. H. AU - Rogers, M. J. PY - 2008 DA - 2008// TI - Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy JO - Osteoporos Int VL - 19 UR - https://doi.org/10.1007/s00198-007-0540-8 DO - 10.1007/s00198-007-0540-8 ID - Russell2008 ER - TY - BOOK AU - Russell, R. G. G. AU - Tsoumpra, M. K. AU - Lawson, M. AU - Chantry, A. D. AU - Ebetino, F. H. AU - Pazianas, M. PY - 2016 DA - 2016// TI - Antiresorptives. Abrahamsen SSaB, editor PB - Springer International CY - Switzerland ID - Russell2016 ER - TY - JOUR AU - Sietsema, W. K. AU - Ebetino, F. H. AU - Salvagno, A. M. AU - Bevan, J. A. PY - 1989 DA - 1989// TI - Antiresorptive dose-response relationships across three generations of bisphosphonates JO - Drugs Exp Clin Res VL - 15 ID - Sietsema1989 ER - TY - JOUR AU - Lepola, V. T. AU - Hannuniemi, R. AU - Kippo, K. AU - Lauren, L. AU - Jalovaara, P. AU - Vaananen, H. K. PY - 1996 DA - 1996// TI - Long-term effects of clodronate on growing rat bone JO - Bone. VL - 18 UR - https://doi.org/10.1016/8756-3282(95)00439-4 DO - 10.1016/8756-3282(95)00439-4 ID - Lepola1996 ER - TY - JOUR AU - Koivukangas, A. AU - Tuukkanen, J. AU - Hannuniemi, R. AU - Jamsa, T. AU - Kippo, K. AU - Jalovaara, P. PY - 2001 DA - 2001// TI - Effects of long-term administration of clodronate on growing rat bone JO - Calcif Tissue Int VL - 69 UR - https://doi.org/10.1007/s00223-001-2036-4 DO - 10.1007/s00223-001-2036-4 ID - Koivukangas2001 ER - TY - JOUR AU - Glorieux, F. H. AU - Bishop, N. J. AU - Plotkin, H. AU - Chabot, G. AU - Lanoue, G. AU - Travers, R. PY - 1998 DA - 1998// TI - Cyclic administration of pamidronate in children with severe osteogenesis imperfecta JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199810013391402 DO - 10.1056/NEJM199810013391402 ID - Glorieux1998 ER - TY - JOUR AU - Henderson, R. C. AU - Lark, R. K. AU - Kecskemethy, H. H. AU - Miller, F. AU - Harcke, H. T. AU - Bachrach, S. J. PY - 2002 DA - 2002// TI - Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial JO - J Pediatr VL - 141 UR - https://doi.org/10.1067/mpd.2002.128207 DO - 10.1067/mpd.2002.128207 ID - Henderson2002 ER - TY - JOUR AU - Falcini, F. AU - Bindi, G. AU - Simonini, G. AU - Stagi, S. AU - Galluzzi, F. AU - Masi, L. PY - 2003 DA - 2003// TI - Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study JO - J Rheumatol VL - 30 ID - Falcini2003 ER - TY - JOUR AU - Freundlich, M. AU - Alon, U. S. PY - 2008 DA - 2008// TI - Bisphosphonates in children with hypercalciuria and reduced bone mineral density JO - Pediatr Nephrol VL - 23 UR - https://doi.org/10.1007/s00467-008-0940-9 DO - 10.1007/s00467-008-0940-9 ID - Freundlich2008 ER - TY - JOUR AU - Escudero, N. D. AU - Mandalunis, P. M. PY - 2012 DA - 2012// TI - Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study JO - Bone Marrow Res VL - 2012 UR - https://doi.org/10.1155/2012/526236 DO - 10.1155/2012/526236 ID - Escudero2012 ER - TY - JOUR AU - Garganta, M. D. AU - Jaser, S. S. AU - Lazow, M. A. AU - Schoenecker, J. G. AU - Cobry, E. AU - Hays, S. R. PY - 2018 DA - 2018// TI - Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta JO - BMC Musculoskelet Disord VL - 19 UR - https://doi.org/10.1186/s12891-018-2252-y DO - 10.1186/s12891-018-2252-y ID - Garganta2018 ER - TY - JOUR AU - Porta-Sales, J. AU - Garzon-Rodriguez, C. AU - Llorens-Torrome, S. AU - Brunelli, C. AU - Pigni, A. AU - Caraceni, A. PY - 2017 DA - 2017// TI - Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: a systematic review within the European Association for Palliative Care guidelines project JO - Palliat Med VL - 31 UR - https://doi.org/10.1177/0269216316639793 DO - 10.1177/0269216316639793 ID - Porta-Sales2017 ER - TY - JOUR AU - Ishchenko, Y. AU - Shakirzyanova, A. AU - Giniatullina, R. AU - Skorinkin, A. AU - Bart, G. AU - Turhanen, P. PY - 2017 DA - 2017// TI - Selective calcium-dependent inhibition of ATP-gated P2X3 receptors by bisphosphonate-induced endogenous ATP analog ApppI JO - J Pharmacol Exp Ther VL - 361 UR - https://doi.org/10.1124/jpet.116.238840 DO - 10.1124/jpet.116.238840 ID - Ishchenko2017 ER - TY - JOUR AU - Kim, S. AU - Seiryu, M. AU - Okada, S. AU - Kuroishi, T. AU - Takano-Yamamoto, T. AU - Sugawara, S. PY - 2013 DA - 2013// TI - Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone JO - Eur J Pharmacol VL - 699 UR - https://doi.org/10.1016/j.ejphar.2012.11.031 DO - 10.1016/j.ejphar.2012.11.031 ID - Kim2013 ER -